A flurry of business activity continues across Emeryville amid the pandemic’s gradual downturn. Covid has helped intensify the demand for life science space and developers are in a “race” to satisfy this. Emeryville has quite a few projects in the development pipeline and is well positioned to build on its reputation as a hub for the sector. Emeryville is already currently home to more than 150 life sciences companies.
Meanwhile, the City of Emeryville is among the many benefactors of these deals as these sales fetch a 1.2% transfer tax that goes toward the city’s general fund.
In other news, Zymergen raised over $500 million through its Initial Public Offering, Lucida Health has forged a relationship with the Warriors and the NBA with their prescription at-home Covid-19 test and DVR-Pioneer TiVo has emerged as the successful bidder at an auction to acquire the assets of bankrupt MobiTV.
The Hollis Business Center in Emeryville traded hands in December.
By Simon Campbell
When Beacon Capital Partners paid $580 per square foot for the 225,459-square-foot Class A Hollis Business Center in Emeryville, it marked a record for the East Bay city. The $130 million paid to BentallGreenOak was another milestone in the continuing development of the North East Bay submarket into a local biotech center.
Boston-based real estate firm Beacon intends to reposition the development for life science companies, and 1480 64th St. was originally constructed for life science use, making the conversion process an easier lift for the new owners. The property is 84% leased to a diverse mix of tenants.
Full story on SF Business Times (paywall may apply)
ADVERTISEMENT [adrotate group="13"]
Longfellow makes first Emeryville deal with life sciences conversion
By Laura Waxmann
Longfellow Real Estate Partners has inked a long-term ground lease for an Emeryville office property with plans to convert it into a Class A life sciences facility.
The project, known as the Atrium at 1650 65th St., represents the Boston life science developer’s first foray into Emeryville.
Full story on SF Business Times (paywall may apply)
KBS Signs More Than 40,000 Square Feet with Two Leases at 593,484 Square-Foot Class A Office Park in Emeryville, CA
KBS, one of the largest investors in commercial real estate, has signed 40,504 square feet in leases with two tenants at The Towers Emeryville, an 593,484 square-foot, Class A office park in Emeryville, California. The Towers Emeryville is owned by KBS Real Estate investment Trust III. The transactions include a new 20,252 square-foot lease with LeapFrog Enterprises, Inc., a global educational entertainment and electronics company, and a 20,252 square-foot lease extension and expansion with Centre for Neuro Skills (CNS), a premier provider of brain injury rehabilitation services with seven locations across California and Texas.
Read more on businesswire.com
How an East Bay company is helping the Warriors — and more NBA teams — fast-break fans to games
By Ron Leuty
Because it’s been a good six months for Lucira Health Inc., it may be a good time for NBA fans.
The small Emeryville company, which in November scored Food and Drug Administration authorization for its $55 prescription at-home Covid-19 test, won the regulator’s blessing Monday for the same test without a prescription. But even before this week’s development, the Golden State Warriors and other National Basketball Association teams started adding Lucira to their reopening rosters.
Full story on SF Business Times (paywall may apply)
‘Biofacturing’ Firm Zymergen Raises $500 Million in Expanded IPO
By Michael Hytha
Zymergen Inc., which uses biological processes to manufacture chemicals, raised $500 million in an upsized initial public offering priced at the top of a marketed range.
The company sold 16.13 million shares Wednesday for $31 each, according to a statement. It had marketed 13.6 million shares for $28 to $31.
Read More on Bloomberg.com
ADVERTISEMENT [adrotate group="13"]

TiVo Corporation Agrees to Acquire MobiTV Assets From Chapter 11 Bankruptcy
Xperi Holding Corporation (Nasdaq: XPER) (the “Company”, “Xperi” or “we”) today announced that its wholly-owned-subsidiary TiVo Corporation was selected as the successful bidder at auction to acquire the assets of MobiTV, a global leader in application-based Pay TV video delivery solutions. The acquisition is in connection with MobiTV’s recently announced Chapter 11 bankruptcy process.
MobiTV delivers a full TV platform, including live and on-demand content, network recording functionality and transport rights. The MobiTV solution provides an attractive extension of TiVo’s IPTV Pay-TV service offerings by adding managed services with the ability to reduce deployment time and onboarding costs. MobiTV will help increase TiVo’s IPTV penetration with U.S. Pay-TV operators enabling them to rapidly launch a branded, fully featured, app-based Pay-TV service. The acquisition includes MobiTV’s patent portfolio, which is highly complementary to Xperi’s existing media patent portfolio.
Full story on Yahoo Finance